Announcements
- Alector to Participate in Upcoming Healthcare Conferences
- Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
- Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
- FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
- Alector Announces Closing of Public Offering
- Alector Announces Pricing of Public Offering of Common Stock
- Alector Announces Proposed Public Offering of Common Stock
- Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
- Alector to Participate in the Stifel Healthcare Conference
More ▼
Key statistics
On Tuesday, Alector Inc (0Z2:STU) closed at 4.78, 38.95% above the 52 week low of 3.44 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.80 |
---|---|
High | 4.96 |
Low | 4.78 |
Bid | 4.70 |
Offer | 4.80 |
Previous close | 4.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 96.38m |
Free float | 86.87m |
P/E (TTM) | -- |
Market cap | 508.91m USD |
EPS (TTM) | -1.56 USD |
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼